Instrument Inactif

Autres langues OHR Pharmaceutical Inc Nasdaq

Actions

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq	05/04
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	26/03
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings	26/03
Top Premarket Decliners	26/03
North American Morning Briefing : Tech in Focus on -2-	25/03
North American Morning Briefing : Investors -2-	18/03
North American Morning Briefing : Stock Futures -2-	11/03
North American Morning Briefing : Traders Await -2-	26/02
NeuBase Therapeutics, Inc. Announces CEO Changes	17/01
North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment	19/12
NeuBase Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
NeuBase Therapeutics : Material Event - Form 8-K	20/10/23
Neubase Therapeutics, Inc. Announces Franklyn G. Prendergast Board of Directors Passed Away	20/10/23
Thinking about buying stock in Navios Maritime Holdings, Biodexa Pharmaceuticals, Iovance Biotherapeutics, Neubase Therapeutics, or Iris Energy?	18/09/23
Thinking about buying stock in Immunitybio, Aurora Cannabis, Elutia, Canopy Growth, or Neubase Therapeutics?	11/09/23
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder	08/09/23
Top Premarket Decliners	07/09/23
Top Midday Gainers	06/09/23
NEUBASE THERAPEUTICS SHARES UP 40% AFTER SYMETRYX CORPORATION AC…	06/09/23
SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE	06/09/23

Aucun résultat pour cette recherche